Prince Pharmaceutical Co., Ltd. Operating Income Margin for the year ending December 31, 2024: -7.15%

Prince Pharmaceutical Co., Ltd. Operating Income Margin is -7.15% for the year ending December 31, 2024, a -309.81% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • Prince Pharmaceutical Co., Ltd. Operating Income Margin for the year ending December 31, 2023 was 3.41%, a -66.83% change year over year.
  • Prince Pharmaceutical Co., Ltd. Operating Income Margin for the year ending December 31, 2022 was 10.28%, a -1,755.53% change year over year.
  • Prince Pharmaceutical Co., Ltd. Operating Income Margin for the year ending December 31, 2021 was -0.62%, a -96.35% change year over year.
  • Prince Pharmaceutical Co., Ltd. Operating Income Margin for the year ending December 31, 2020 was -17.00%, a 355.97% change year over year.
Key Data
Date Operating Income Margin Gross Profit Margin EBIT Margin EBITDA Margin